Under specific conditions, the United States Department of Health and Human Services does not intend to take enforcement action against certain peptide compounders while an FDA formal evaluation process continues

Drug Policy, Pricing & Approval

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

1 debate·7,810 claims·640 news stories

Opening sign-in…